CDKN2A, cyclin dependent kinase inhibitor 2A, 1029

N. diseases: 115; N. variants: 105
Disease: Malignant neoplasm of urinary bladder ×
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005684
Disease: Malignant neoplasm of urinary bladder
Malignant neoplasm of urinary bladder 		0.400 Biomarker disease CTD_human We, therefore, examined, in a population-based study of human bladder cancer, the relationship between epigenetic silencing of three tumor suppressor genes, p16(INK4A), RASSF1A and PRSS3, and exposure to both tobacco and arsenic in bladder cancer. 15987713 2006
CUI: C0005684
Disease: Malignant neoplasm of urinary bladder
Malignant neoplasm of urinary bladder 		0.400 Therapeutic disease CTD_human We, therefore, examined, in a population-based study of human bladder cancer, the relationship between epigenetic silencing of three tumor suppressor genes, p16(INK4A), RASSF1A and PRSS3, and exposure to both tobacco and arsenic in bladder cancer. 15987713 2006
CUI: C0005684
Disease: Malignant neoplasm of urinary bladder
Malignant neoplasm of urinary bladder 		0.400 Therapeutic disease CTD_human Effect of Ad-p16 combined with CDDP or As2O3 on human bladder cancer cells. 12973940 2003
CUI: C0005684
Disease: Malignant neoplasm of urinary bladder
Malignant neoplasm of urinary bladder 		0.400 Biomarker disease CTD_human Effect of Ad-p16 combined with CDDP or As2O3 on human bladder cancer cells. 12973940 2003